Home › NDC Lookup › RxCUI directory › RxCUI 903879

24 HR fluvoxamine maleate 150 MG Extended Release Oral Capsule — RxCUI 903879

RxNorm drug concept · Semantic clinical drug
RxCUI 903879 Semantic clinical drug · SCD ● Current RxNorm concept 12 FDA products 16 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI903879
Official name24 HR fluvoxamine maleate 150 MG Extended Release Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asfluvoxaMINE maleate 150 MG 24HR Extended Release Oral Capsule
FDA products mapped12
Package NDCs mapped16
Reported Medicaid activity (SDUD)27,726 prescriptions · 41 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Fluvoxamine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Great question. Fluvoxamine is in the SSRI family, which includes many antidepressants, but for these products it's specifically approved to treat obsessive-compulsive disorder (OC...
  • What exactly does fluvoxamine treat — I thought it was an antidepressant?
  • Fluvoxamine isn't a quick fix — it takes time. Doses start low and are increased gradually over several weeks, and meaningful symptom relief with OCD can take a number of weeks aft...
  • Nausea is one of the most common early side effects and often improves as your body adjusts. You may also notice drowsiness, sweating, shakiness, diarrhea, or decreased appetite. T...
📖 Read our full Fluvoxamine guide →

🕸️ Concept Web — How 24 HR fluvoxamine maleate 150 MG Extended Releas... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 24 HR fluvoxamine maleate 150 MG Extended Release Oral Capsule RxCUI 903879

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Fluvoxamine 42355
    • Fluvoxamine maleate 203143
  2. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Fluvoxamine Extended Release Oral Capsule 790408
    • Fluvoxamine maleate Extended Release Oral Capsule 2646592
    • Fluvoxamine Oral Product 1161460
    • Fluvoxamine Pill 1161461
    • Fluvoxamine maleate Oral Product 2660966
    • Fluvoxamine maleate Pill 2660194
    • Extended Release Oral Capsule 316943
    • Oral Product 1151131
    • +1 more in this family
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Fluvoxamine maleate 150 MG 903878

Showing up to 8 concepts per family — 11 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Fluvoxamine maleate 150 MG SCDC · 903878
  • Fluvoxamine Extended Release Oral Capsule SCDF · 790408
  • Fluvoxamine maleate Extended Release Oral Capsule SCDFP · 2646592
  • Fluvoxamine Oral Product SCDG · 1161460
  • Fluvoxamine Pill SCDG · 1161461
  • Fluvoxamine maleate Oral Product SCDGP · 2660966
  • Fluvoxamine maleate Pill SCDGP · 2660194

📦 FDA Products & Package NDCs

12 products · 16 package NDCs
16 package NDCs map to RxCUI 903879 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00228-2848-03 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0228-2848-03) Fluvoxamine Maleate Actavis Pharma, Inc. 2014-08-05
00228-2849-03 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0228-2849-03) Fluvoxamine Maleate Actavis Pharma, Inc. 2014-08-05
10370-0175-11 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10370-175-11) Fluvoxamine Maleate Endo USA, Inc. 2013-03-13
10370-0176-11 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10370-176-11) Fluvoxamine Maleate Endo USA, Inc. 2013-03-13
27241-0274-30 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (27241-274-30) Fluvoxamine Maleate Ajanta Pharma USA Inc. 2024-10-17
27241-0275-30 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (27241-275-30) Fluvoxamine Maleate Ajanta Pharma USA Inc. 2024-10-17
31722-0064-01 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (31722-064-01) Fluvoxamine Maleate Camber Pharmaceuticals, Inc. 2025-07-30
31722-0064-30 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (31722-064-30) Fluvoxamine Maleate Camber Pharmaceuticals, Inc. 2025-07-30
31722-0065-01 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (31722-065-01) Fluvoxamine Maleate Camber Pharmaceuticals, Inc. 2025-07-30
31722-0065-30 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (31722-065-30) Fluvoxamine Maleate Camber Pharmaceuticals, Inc. 2025-07-30
69452-0182-13 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (69452-182-13) Fluvoxamine Maleate Bionpharma Inc. 2020-12-01
69452-0182-32 1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (69452-182-32) Fluvoxamine Maleate Bionpharma Inc. 2020-12-01
69452-0183-13 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (69452-183-13) Fluvoxamine Maleate Bionpharma Inc. 2020-07-01
69452-0183-32 1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (69452-183-32) Fluvoxamine Maleate Bionpharma Inc. 2020-07-01
73190-0066-30 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (73190-066-30) Fluvoxamine Maleate AvKARE 2025-12-04
73190-0067-30 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (73190-067-30) Fluvoxamine Maleate AvKARE 2025-12-04
Observed labelers: Bionpharma Inc. (4) · Camber Pharmaceuticals, Inc. (4) · Actavis Pharma, Inc. (2) · Ajanta Pharma USA Inc. (2) · AvKARE (2) · Endo USA, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.